Grasp-Release Assessment of a Networked Neuroprosthesis Device
A legfontosabb adatok
- Ki végzi
- MetroHealth Medical Center
- Hol
- Cleveland (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 13 fő, tervezett
- Kezdés
- 2022. jan. 23.
- Várható befejezés
- 2028. dec. 1.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- Networked Neuroprosthesis Device
- A regiszteradat frissítve
- 2025. december 19.
Ki vehet részt
The trial is looking for people with a spinal cord injury in the neck who would get an implanted device to help move the arm and hand.
- Életkor
- Older than 16 years.
- Nem
- Male or female.
- A betegség stádiuma
- Neck-level spinal cord injury, motor level C1 to C7, AIS grade A, B or C. Injury happened 6 months or more ago. Some arm and hand muscles still react to electrical stimulation, with good upper arm strength.
- Korábbi kezelés
- People who had nerve transfer or tendon transfer surgery on the arm must be stable after it (typically one year after nerve transfer, 6 months after tendon transfer).
- A részvétel fő kizáró okai
- Other nerve conditions, such as MS or diabetes affecting the nerves, or a nerve injury in the arm or shoulder
- Spinal cord injury that is getting worse, or other neck spine problems
- An active implanted device such as a pacemaker or defibrillator
- Dependence on a breathing machine, or a condition that needs MRI monitoring
- Currently pregnant, or an active untreated infection
A regiszter összes feltétele (23)A regiszter feltételeinek elrejtése
Ki vehet részt
- Male or female, age > 16 years
- Cervical level spinal cord injury, as defined by:; International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) motor level of C1 through C7 and; American Spinal Injury Association (ASIA) Impairment Scale (AIS) grade A, B, or C
- Six months or more post-injury (neurostability)
- Neurologically stable following any nerve transfers affecting the upper extremity (typically, one year post surgery)
- Musculoskeletally and neurologically stable following any tendon transfers affecting the upper extremity (typically, 6-months)
- Peripheral nerve innervation to upper extremity muscles, including a grade 3/5 or higher Stimulated Manual Muscle Test (SMMT) strength in at least two of the following muscles in one arm:; Adductor Pollicus, Abductor Pollicus Brevis (AbPB), Flexor Pollicus Longus (FPL), Extensor Pollicus Longus (EPL)/Extensor Pollicus Brevis (EPB), Extensor Digitorum Communis (EDC), Flexor Digitorum Superficialis (FDS), Flexor Digitorum Profundus (FDP), Pronator Quadratus (PQ), Extensor Carpi Ulnaris (ECU), Extensor Carpi Radialis Brevis (ECRB), Extensor Carpi Radialis Longus (ECRL), Flexor Carpi Ulnaris (FCU), Flexor Carpi Radialis (FCR), First Dorsal Interosseous(1DI), triceps,; At least two of the grade 3/5 or higher excitable muscles must also have grade 2/5 or lower voluntary strength
- Good proximal upper extremity strength as defined by biceps/brachialis/brachioradialis strength of 2/5 or higher on Manual Muscle Test on the side intended for implantation
- Medically stable
- Able to understand and provide informed consent
Ki nem vehet részt
- Involvement in other ongoing clinical studies that exclude concurrent involvement in this study
- Other neurological conditions (MS(multiple Sclerosis), diabetes with peripheral nerve involvement); Associated peripheral nerve / brachial plexus injury
- Active untreated infection such as pressure injury, urinary tract infection, pneumonia
- History of coagulopathy, HIV, cardiopulmonary disease, bradycardia, poorly controlled autonomic dysreflexia, or chronic obstructive pulmonary disease that would preclude safe participation in the trial as determined by the investigator
- Disorder or condition that requires MRI monitoring
- Presence of disease that might interfere with participant safety, compliance, or evaluation of the condition under study
- Progressive SCI
- Co-existing cervical spine pathology (syrinx, unstable segment)
- Active implantable medical device (AIMD) such as a pacemaker or defibrillator
- Unhealed fractures that prevent functional use of arm
- Extensive upper extremity denervation (fewer than two excitable hand muscles)
- Mechanical ventilator dependency
- Currently pregnant (neuroprosthesis implantation delayed until no longer pregnant)
- Other significant medical findings that, in the opinion of the investigator, preclude safe participation in the trial
Alkalmassági kérdőív
Ez nem döntés: hogy ki vehet részt, azt csak a vizsgálat csapata mondhatja meg.
- Életkor
- Spinal cord injuries vagy spinal cord injury cervical
Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.
- MetroHealth Medical CenterCleveland, Egyesült ÁllamokContact: Anne Bryden, Ph.D, OTR/LRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The overall objective of this trial is to characterize the safety and effectiveness of the Networked Neuroprosthesis Device - Upper Extremity (NP-UE) in individuals living with cervical SCI.
A vizsgálat csoportja
- Experimental: Intervention - implant neuroprosthesisA vizsgált kezelés
Receives implanted networked neuroprosthetic system for arm and hand function. Undergoes functional training and assessment.
Kezelés: Networked Neuroprosthesis Device
Következő lépések
Az orvosodnak
Kérdőlap az orvosnak
PDF az orvosodnak: mit vizsgál a vizsgálat, ki vehet részt, és 2 kérdés a részvételi feltételekről, hellyel a válaszoknak és a jegyzeteknek.
PDF, US Letter, 1–2 oldal. A4 méretben
A vizsgálati csapatnak
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Kérdések a feltételekről
- Forrás: NCT05863754: ki vehet részt
- A regiszteradat frissítve
- 2025. december 19.